Enter Your Practice Information





Yes No

Yes No


X
x

Welcome to the all-new Vetlearn

  • What’s new on Vetlearn?
  • The latest issues of Compendium and
    Veterinary Technician
  • New CE articles for veterinarians and technicians
  • Expert advice on practice management
  • Care guides on more than 400 subjects
    to give to your clients
  • And more!

To access Vetlearn, you must first sign in or register.

registernow

Become a Member

Journal January 2009 (Vol 31, No 1)

NOTE: You have already passed this course.
NOTE: This course is no longer valid for accreditation purposes.

Immunosuppressive Therapy for Canine Immune-Mediated Hemolytic Anemia CE Article #3 by Suliman Al-Ghazlat , BVSc, DACVIM

1. Which statement regarding dogs with IMHA is correct?
2. Which statement regarding glucocorticoid therapy for treating IMHA is correct?
3. Which statement regarding immunosuppressive agents used to treat canine IMHA is correct?
4. Which statement regarding the mechanism of action of immunosuppressive agents is incorrect?
5. Which is not a reported side effect of cyclosporine therapy in dogs?
6. Which is not a side effect of azathioprine therapy in dogs?
7. Which is not a side effect of glucocorticoids?
8. Which patient is the most suitable candidate for hIVIG treatment?
9. Which immunosuppressive therapy is unlikely to be effective in the first 2 weeks of treating IMHA?
10. In dogs with IMHA, administration of which immunosuppressive drug has been associated with a worse outcome in retrospective studies?
Stay on top of all our latest content — sign up for the Vetlearn newsletters.
  • More
Subscribe